GSH-treated fat grafts present a better histological structure H&E staining showed that the fat grafts in the GSH-treated group exhibited better morphologic integrity, with fewer vacuoles, fibrotic cells, and inflammatory cells (Fig
Barchini J, Tchachaghian S, Shamaa F, Jabbur SJ, Meyerson BA, Song Z, et al
Common side effects documented across GLP-1 clinical trials include nausea, vomiting, diarrhea, constipation, and injection-site reactions
The investigators found that compared with metformin, GLP-1 RA therapy was associated with the following: A 26% reduction in all-cause mortality A 13% reduction in hospitalizations Up to a 48% reduction in amputations An approximately 36% reduction in revascularization procedures in obstructed lower extremity arteries Rates of myocardial infarction, stroke, and serious kidney events were similar between the treatment groups
Genetic Predispositions Genetic predispositions, including mutations in genes, can elevate the risk of ovarian cysts